Key facts
- This page summarizes Michael Chi's Form 4 filing for Hims & Hers Health, Inc. (HIMS).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 Nov 2024, 18:32.
Michael Chi - 25 Nov 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- HIMS
- Reported as of
- 25 Nov 2024
- Net transaction value
- -$371,668
- SEC form
- 4
- Accepted by SEC
- 26 Nov 2024, 18:32:34 UTC
- Prior SEC filing
- 19 Nov 2024
- Next SEC filing
- 03 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Chi filed Form 4 for Hims & Hers Health, Inc. (HIMS) on 26 Nov 2024.
Change
- Previous filing in this sequence was filed on 19 Nov 2024.
- Current net transaction value: -$371,668.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HIMS
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $86,688
- Shares
- +17,303
- Change %
- +9.4%
- Price
- $5.01
- Shares after
- 201,283
- Date
- 25 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
HIMS
transaction
Class A Common Stock
Sale
- Transaction value
- $458,356
- Shares
- -17,303
- Change %
- -8.6%
- Price
- $26.49
- Shares after
- 184,947
- Date
- 25 Nov 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HIMS
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -17,303
- Change %
- -6.2%
- Price
- $0.000000
- Shares after
- 259,552
- Date
- 25 Nov 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 17,303
- Exercise price
- $5.01
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024 by the Reporting Person.
Footnote F2
Includes 967 shares acquired on November 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.
Footnote F3
The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.